Ventoaldo 100 mcg/dose suspension for inhalation in pressurized container

Package leaflet: Information for the user

Introduction

Package leaflet: information for the user

Ventoaldo 100 micrograms/dose inhalation suspension in pressurised container

Salbutamol

Read all of this leaflet carefully before you start using this medicine, because it contains important information for you.

• Keep this leaflet, as you may need to read it again. If you have any questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only, and you should not give it to other people, even if they have the same symptoms as you, because it may harm them.
• If you experience any adverse effects, consult your doctor or pharmacist, even if they are adverse effects not listed in this leaflet. See section 4.

Leaflet contents

1. What Ventoaldo 100 micrograms/dose is and what it is used for
2. What you need to know before using Ventoaldo 100 micrograms/dose
3. How to use Ventoaldo 100 micrograms/dosis
4. Possible adverse effects
5. How to store Ventoaldo 100 micrograms/dose
6. Contents of the pack and other information

1. What Ventoaldo 100 micrograms/dose is and what it is used for

Salbutamol belongs to a group of medicines called bronchodilators, which work by relaxing the muscles in the walls of the small airways of the lungs. It makes breathing easier and relieves cough.

• Symptomatic treatment of bronchospasm (narrowing of the airways in the lungs) in bronchial asthma and in other conditions associated with reversible obstruction of the airways. These are a group of lung diseases that cause inflammation of the airways, resulting in blockage of airflow in the lungs.
• Prevention of exercise-induced bronchospasm (narrowing of the airways in the lungs), or prior to exposure to a known and unavoidable allergenic stimulus (a substance capable of causing an allergic reaction).

2. What you need to know before using Ventoaldo 100 micrograms/dose

Do not use Ventoaldo 100 micrograms/dose:

• If you are allergic to salbutamol or to any of the other components of this medicine (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before starting to use this medicine:

• If you have a history of heart disease, irregular heartbeat, or angina pectoris.
• If you suffer from thyrotoxicosis, diabetes mellitus, severe cardiovascular disorders, or hypertension (high blood pressure).
• If your condition worsens during treatment, you must see your doctor, as you may require alternative therapy.

Other medicines and Ventoaldo 100 micrograms/dose

Inform your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines.

It is important to inform your doctor if you are taking any of the following medicines:

• Non-cardioselective beta-blockers, as they are contraindicated in asthmatic patients. Propranolol and similar agents antagonize the effects of salbutamol.
• During treatment with salbutamol, it is preferable not to administer imipramine, chlorpromazine, or chlordiazepoxide.
• Medicines that reduce serum potassium levels, as concomitant administration may result in additive effects.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medicine.

The use of salbutamol during pregnancy is not recommended; it should only be administered if, in the physician’s judgment, the expected benefit to the mother outweighs any possible risk to the fetus.

If administration is required in a breastfeeding mother, replacement of natural breastfeeding is recommended.

Driving and use of machines:

Although effects on the ability to drive or operate machinery are not expected, you should be aware of the possibility of muscle cramps and tremors.

Use in athletes

This medicine contains salbutamol, which may produce a positive result in doping control tests.

Ventoaldo 100 micrograms/dose contains ethanol

This medicine contains 3 mg of alcohol (ethanol) per actuation. The amount per actuation of this medicine is equivalent to less than 1 ml of beer or 1 ml of wine. The small amount of alcohol contained in this medicine does not produce any perceptible effect.

3. How to use Ventoaldo 100 micrograms/dose

Follow exactly the instructions for using this medicine as given by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.

Remember to take your medicine.

This medicine is administered by inhalation.

Ventoaldo 100 micrograms/dose should be used on an as-needed basis and not on a regular schedule.

If your asthma is active (for example, you have symptoms or frequent attacks such as difficulty breathing that interferes with speaking, eating, or sleeping, coughing, wheezing, chest tightness, or limited physical capacity), you must inform your doctor immediately. Your doctor may start you on medication or increase your treatment dose, such as an inhaled corticosteroid, to control your asthma.

Inform your doctor as soon as possible if your medicine does not seem to be working as well as usual (for example, if you need higher doses to relieve breathing problems or if your inhaler does not provide relief for at least 3 hours), since your asthma may be worsening and you may require a different medicine.

If you use Ventoaldo 100 micrograms/dose more than twice a week to treat your asthma symptoms, excluding preventive use before exercise, this indicates poorly controlled asthma and may increase the risk of severe asthma attacks (worsening of asthma) that can lead to serious complications and may be life-threatening or even fatal. You should contact your doctor as soon as possible to review your asthma treatment.

If you are taking a daily anti-inflammatory medicine for your lungs, e.g., an “inhaled corticosteroid,” it is important that you continue using it regularly, even if you feel better.

The recommended dose is:

Adults

To relieve acute bronchospasm and treat intermittent asthma episodes, one inhalation may be administered as a single dose, which may be increased to two inhalations if necessary. If the response is inadequate, higher doses than two inhalations may be used. The maximum recommended dose is two inhalations, three or four times daily.

To prevent exercise-induced bronchospasm, one or two inhalations should be administered 15 minutes before exercise.

One or two inhalations may be administered before anticipated exposure to allergens.

Use in elderly patients:

Same recommendations as for adults.

Use in children and adolescents

The recommended dose to relieve acute bronchospasm in the treatment of episodic asthma or to prevent exercise-induced asthma is one inhalation. If the response is inadequate, higher doses than one inhalation may be administered.

It is very important that you follow the instructions given by your doctor.

Instructions for correct administration of the preparation:

1. Remove the cap (fig. 1). If this is a new inhaler or has not been used for several days, shake the inhaler (fig. 2) and release one puff to ensure proper functioning of the inhaler. If the inhaler is used regularly, proceed to the following instructions:
2. Shake the inhaler (fig. 2).
3. Empty your lungs of as much air as possible.
4. Place the inhaler in your mouth in the position shown in the drawing (fig. 3).
5. Take as deep a breath as possible.

Press down on the device, following the arrows shown in the drawing (fig. 4), while inhaling.

1. Remove the inhaler from your mouth and try to hold your breath for a few seconds.
2. You must clean the mouthpiece actuator of the inhaler periodically. To do this, remove the actuator from the inhaler and clean it with a cloth or paper towel.
3. Store with the cap on to protect it from dust and dirt.

The inhaler has a dose indicator visible through a small hole or window on the actuator, which shows how many doses remain. On a new inhaler, the number “200” can be seen through the actuator window. This number corresponds to the number of doses remaining in the inhaler. As the inhaler is used, the dose indicator rotates downward every 5–7 actuations until it reaches 0.

When approximately 40 doses remain, the indicator changes from green to red (see figure 5) to remind the patient to consult their doctor about whether treatment should continue or if a new prescription is needed. Discard the inhaler once the indicator reaches “0”.

(figure 5)

If you use more Ventoaldo 100 micrograms/dose than you should

In case of overdose or accidental ingestion, contact your doctor or pharmacist immediately or call the Toxicology Information Service at telephone number 91 562 04 20, indicating the medicine and the amount ingested.

If a larger than recommended dose is taken, peripheral vasodilation, increased heart rate, and skeletal muscle tremor may occur. This symptomatology resolves rapidly and spontaneously. To counteract the effects of beta-adrenergic stimulation, cardioselective beta-blockers (practolol) may be used. Other adrenergic beta-blockers are not recommended, as they may cause bronchoconstriction in asthmatics. In the event of ventricular arrhythmia occurring during acute intoxication, slow intravenous infusion of potassium chloride, 40 mEq in 500 ml of 5% dextrose for injection, is recommended.

If you forget to use Ventoaldo 100 micrograms/dose

Do not take a double dose to make up for missed doses. Inhale the next dose at the scheduled time, or earlier if you experience breathlessness or “wheezing.”

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible adverse effects

Like all medicines, this medicine can cause adverse effects, although not everyone experiences them.

The adverse effects are dose-dependent and are due to the mechanism of action of beta-2 agonists.

Although it is not exactly known how frequently this occurs, some people may occasionally experience chest pain (due to heart problems such as angina pectoris). Inform your doctor if you develop these symptoms while being treated with salbutamol, but do not stop taking this medicine unless your doctor tells you to.

Very rarely, allergic reactions have been reported, including angioedema (swelling of the deeper layers of the skin, appearing as large hives around the eyes and lips, and possibly affecting the hands, feet, and throat), urticaria, bronchospasm, hypotension (low blood pressure), and fainting.

Disorders of the cardiovascular and lymphatic systems: potentially serious hypokalemia may occur as a result of systemic treatment with beta-2 agonists.

Psychiatric disorders: nervousness, feeling of tension. As with other beta-2 agonists, hyperactivity in children has rarely been reported.

Nervous system disorders: mild tremor, headache, dizziness.

Cardiovascular disorders: tachycardia, angioedema, hypotension. Cases of cardiac arrhythmias (including atrial fibrillation, supraventricular tachycardia, and extrasystoles) have been reported in association with beta-2 agonists, usually in susceptible patients.

Respiratory, thoracic and mediastinal disorders: as with other inhaled therapies, the possibility of paradoxical bronchospasm, with an immediate increase in wheezing after administration, should be considered.

Gastrointestinal disorders: nausea.

Skin and subcutaneous tissue disorders: urticaria.

Musculoskeletal, connective tissue and bone disorders: transient muscle cramps have rarely been reported.

General disorders and administration site conditions: oral and pharyngeal irritation may occur.

If you notice any other adverse reaction not described above, consult your doctor or pharmacist.

Reporting of adverse effects:

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this leaflet. You may also report them directly via the Spanish Pharmacovigilance System for Human Medicines: https://www.notificaram.es By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Storage of Ventoaldo 100 micrograms/dose

Keep this medicine out of the sight and reach of children.

Do not store above 30 ºC. Store in the original packaging to protect from light. Do not freeze.

The container contains a pressurized liquid. Do not expose to temperatures above 50 ºC. Do not pierce the container even when it appears to be empty.

Do not use this medicine after the expiry date stated on the label and carton following EXP. The expiry date refers to the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Dispose of containers and unused medicines at the SIGRE collection point at your pharmacy. If you are unsure, ask your pharmacist how to dispose of containers and unused medicines. This will help protect the environment.

6. Contents of the pack and other information

Composition of Ventoaldo 100 micrograms/dose

• The active substance is salbutamol base (equivalent to 120 micrograms of salbutamol sulfate).

• The other components (excipients) are oleic acid, ethanol, and norflurane (HFA-134a).

This medicine contains fluorinated greenhouse gases.

Each inhaler contains 13.05 g of norflurane (HFA-134a), equivalent to 0.0187 tonnes of CO2 (global warming potential GWP = 1,430).

Appearance of the product and contents of the pack

Ventoaldo 100 micrograms/dose is presented as a suspension in a pressurized container with a dose indicator; each carton contains one 10 ml container providing 200 actuations.

Hospital pack: box containing 20 containers of 10 ml with 200 actuations each.

Only certain pack sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Laboratorio Aldo-Unión, S.L.

Baronesa de Maldá, 73

08950 Esplugues de Llobregat (Barcelona)

Spain

Date of the most recent revision of this leaflet: April 2026.

Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es